{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":42096,"items":[{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:32:32Z","timestamp":1707525152156},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2023,7,14]]},"DOI":"10.7759\/cureus.41896","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T19:51:42Z","timestamp":1689364302000},"source":"Crossref","is-referenced-by-count":0,"title":["Endoscopic Glucocorticoid Injection for the Treatment of a Refractory Benign Esophageal Stenosis in a Patient With Plummer-Vinson Syndrome"],"prefix":"10.7759","author":[{"given":"Kegan","family":"Jessamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Jessamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Obiajulu","family":"Anozie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.929899","article-title":"Plummer-Vinson syndrome: a rare cause of dysphagia in an octogenarian","volume":"22","author":"Harmouch F","year":"2021","unstructured":"Harmouch F, Liaquat H, Chaput KJ, Geme B. Plummer-Vinson syndrome: a rare cause of dysphagia in an octogenarian. Am J Case Rep. 2021, 22:e929899. 10.12659\/AJCR.929899","journal-title":"Am J Case Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3109\/00016923909174880","article-title":"The roentgenological diagnosis of sideropenic dysphagia","volume":"20","author":"Waldenstrom J","year":"1939","unstructured":"Waldenstrom J, Kjellberg SR. The roentgenological diagnosis of sideropenic dysphagia. Acta Radiol. 1939, 20:618-38. 10.3109\/00016923909174880","journal-title":"Acta Radiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70001-9","article-title":"Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data","volume":"1","author":"Stevens GA","year":"2013","unstructured":"Stevens GA, Finucane MM, De-Regil LM, et al.. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health. 2013, 1:e16-25. 10.1016\/S2214-109X(13)70001-9","journal-title":"Lancet Glob Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/2631774519862134","article-title":"Endoscopic management of refractory benign oesophageal strictures","volume":"12","author":"Everett SM","year":"2019","unstructured":"Everett SM. Endoscopic management of refractory benign oesophageal strictures. Ther Adv Gastrointest Endosc. 2019, 12:2631774519862134. 10.1177\/2631774519862134","journal-title":"Ther Adv Gastrointest Endosc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-814520","article-title":"Factors influencing clinical applications of endoscopic balloon dilation for benign esophageal strictures","volume":"36","author":"Chiu YC","year":"2004","unstructured":"Chiu YC, Hsu CC, Chiu KW, Chuah SK, Changchien CS, Wu KL, Chou YP. Factors influencing clinical applications of endoscopic balloon dilation for benign esophageal strictures. Endoscopy. 2004, 36:595-600. 10.1055\/s-2004-814520","journal-title":"Endoscopy"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2016.04.035","article-title":"Treatment of refractory benign esophageal strictures: it is all about being \"patient\"","volume":"84","author":"Siersema PD","year":"2016","unstructured":"Siersema PD. Treatment of refractory benign esophageal strictures: it is all about being \"patient\". Gastrointest Endosc. 2016, 84:229-31. 10.1016\/j.gie.2016.04.035","journal-title":"Gastrointest Endosc"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7619298","article-title":"Efficacy and safety of endoscopic intralesional triamcinolone injection for benign esophageal strictures","volume":"2018","author":"Zhang YW","year":"2018","unstructured":"Zhang YW, Wei FX, Qi XP, Liu Z, Xu XD, Zhang YC. Efficacy and safety of endoscopic intralesional triamcinolone injection for benign esophageal strictures. Gastroenterol Res Pract. 2018, 2018:7619298. 10.1155\/2018\/7619298","journal-title":"Gastroenterol Res Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-1-36","article-title":"Plummer-Vinson syndrome","volume":"1","author":"Novacek G","year":"2006","unstructured":"Novacek G. Plummer-Vinson syndrome. Orphanet J Rare Dis. 2006, 1:36. 10.1186\/1750-1172-1-36","journal-title":"Orphanet J Rare Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00855","article-title":"Drugs and targets in fibrosis","volume":"8","author":"Li X","year":"2017","unstructured":"Li X, Zhu L, Wang B, Yuan M, Zhu R. Drugs and targets in fibrosis. Front Pharmacol. 2017, 8:855. 10.3389\/fphar.2017.00855","journal-title":"Front Pharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2005.00331.x","article-title":"A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures","volume":"100","author":"Ramage JI Jr","year":"2005","unstructured":"Ramage JI Jr, Rumalla A, Baron TH, et al.. A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol. 2005, 100:2419-25. 10.1111\/j.1572-0241.2005.00331.x","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1067\/mge.2002.129871","article-title":"Usefulness of intralesional triamcinolone in treatment of benign esophageal strictures","volume":"56","author":"Kochhar R","year":"2002","unstructured":"Kochhar R, Makharia GK. Usefulness of intralesional triamcinolone in treatment of benign esophageal strictures. Gastrointest Endosc. 2002, 56:829-34. 10.1067\/mge.2002.129871","journal-title":"Gastrointest Endosc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2023.03.017","article-title":"Predictors of stricture after non-circumferential endoscopic submucosal dissection of the esophagus and single-dose triamcinolone injection immediately after the procedure [in press]","author":"Miyake M","year":"2023","unstructured":"Miyake M, Ishihara R, Matsuura N, et al.. Predictors of stricture after non-circumferential endoscopic submucosal dissection of the esophagus and single-dose triamcinolone injection immediately after the procedure [in press]. Gastrointest Endosc. 2023, 10.1016\/j.gie.2023.03.017","journal-title":"Gastrointest Endosc"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0253-y","article-title":"Endoscopic balloon dilation followed by intralesional steroid injection for anastomotic strictures after esophagectomy: a randomized controlled trial","volume":"113","author":"Hanaoka N","year":"2018","unstructured":"Hanaoka N, Ishihara R, Motoori M, et al.. Endoscopic balloon dilation followed by intralesional steroid injection for anastomotic strictures after esophagectomy: a randomized controlled trial. Am J Gastroenterol. 2018, 113:1468-74. 10.1038\/s41395-018-0253-y","journal-title":"Am J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.348","article-title":"Endoscopic management of difficult or recurrent esophageal strictures","volume":"106","author":"de Wijkerslooth LR","year":"2011","unstructured":"de Wijkerslooth LR, Vleggaar FP, Siersema PD. Endoscopic management of difficult or recurrent esophageal strictures. Am J Gastroenterol. 2011, 106:2080-91; quiz 2092. 10.1038\/ajg.2011.348","journal-title":"Am J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.01.016","article-title":"Endoscopic corticosteroid injections do not reduce dysphagia after endoscopic dilation therapy in patients with benign esophagogastric anastomotic strictures","volume":"11","author":"Hirdes MM","year":"2013","unstructured":"Hirdes MM, van Hooft JE, Koornstra JJ, et al.. Endoscopic corticosteroid injections do not reduce dysphagia after endoscopic dilation therapy in patients with benign esophagogastric anastomotic strictures. Clin Gastroenterol Hepatol. 2013, 11:795-801.e1. 10.1016\/j.cgh.2013.01.016","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Cureus"],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/169705-endoscopic-glucocorticoid-injection-for-the-treatment-of-a-refractory-benign-esophageal-stenosis-in-a-patient-with-plummer-vinson-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:52Z","timestamp":1707509152000},"score":21.503859,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/169705-endoscopic-glucocorticoid-injection-for-the-treatment-of-a-refractory-benign-esophageal-stenosis-in-a-patient-with-plummer-vinson-syndrome"}},"issued":{"date-parts":[[2023,7,14]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.41896","ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"published":{"date-parts":[[2023,7,14]]}},{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:17:15Z","timestamp":1786547835328,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Am J Gastroenterol"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>INTRODUCTION:<\/jats:title>\n                    <jats:p>H. pylori contributes to approximately 75 % of stomach cancers internationally. Gastric MALT lymphoma is a rare disease with an incidence of 0.38 per 100,000 people in the United States of America (USA). The majority of gastric MALT lymphoma cases are cured with H pylori eradication therapy while chemotherapy is the mainstay of treatment for gastric diffuse large B-cell lymphoma (DLBCL). Gastric high grade DLBCL is rare and there is limited data in which treatment with H pylori eradication can attain complete remission. We present a case of a woman with DLBCL and was treated for H pylori and attained complete remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CASE DESCRIPTION\/METHODS:<\/jats:title>\n                    <jats:p>A 59 year old woman presented to our clinic for evaluation of epigastric pain for 2 months. A trial of Prior proton pump inhibitor (PPI) treatment did not improve her pain. Abdominal CT imaging was significant only for diverticulosis. Esophagogastroduodenoscopy (EGD) showed a 25 mm non-bleeding cratered gastric ulcer with pigmented material at the incisura of the stomach. Incisiural biopsies revealed high grade B cell lymphoma and antral\/body biopsies showed H pylori. PET CT imaging showed diffuse fluorodeoxyglucose uptake along the lesser curvature of the stomach corresponding to the known area of lymphoma. There was no evidence of metastatic disease. The patient declined chemotherapy due to fear of associated side effects. Instead, she was given H pylori quadruple therapy with a 14 day course of Pantoprazole, Bismuth subsalicylate, Metronidazole, and Tetracycline. Repeat EGD with endoscopic ultrasound at 1 and 4 months later were unremarkable and biopsies at the site of the healed ulcer were negative for neoplasia. To date, she remains asymptomatic.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>To date, there is no established standard management strategy for primary gastric lymphoma. Major guidelines recommend chemotherapy as the initial treatment for DLBCL. The efficacy of HP eradication for gastric pure DLBCL has mostly remained unknown, with limited data available. Despite histological remission, lymphoma recurrence is possible. Given the limited data available, long term, careful follow-up should be done for all patients if they are treated with antibiotics for DLBCL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.14309\/01.ajg.0000600296.85582.9b","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T12:16:29Z","timestamp":1570536989000},"page":"S1485-S1486","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["2691\u2003Quadruple Therapy: A Cure for Gastric High Grade B-Cell Lymphoma?"],"prefix":"10.14309","volume":"114","author":[{"given":"Kegan","family":"Jessamy","sequence":"first","affiliation":[{"name":"State University of New York Upstate Medical University, Syracuse, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Ozden","sequence":"additional","affiliation":[{"name":"State University of New York Upstate Medical University, Syracuse, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marsha","family":"Antoine","sequence":"additional","affiliation":[{"name":"State University of New York Upstate Medical University, Syracuse, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Tambe","sequence":"additional","affiliation":[{"name":"State University of New York Upstate Medical University, Syracuse, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["American Journal of Gastroenterology"],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.14309\/01.ajg.0000600296.85582.9b","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:18:15Z","timestamp":1786544295000},"score":21.244202,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.14309\/01.ajg.0000600296.85582.9b"}},"issued":{"date-parts":[[2019,10]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.14309\/01.ajg.0000600296.85582.9b","ISSN":["0002-9270","1572-0241"],"issn-type":[{"value":"0002-9270","type":"print"},{"value":"1572-0241","type":"electronic"}],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"2019-07-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]},{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:10:55Z","timestamp":1781017855727,"version":"3.54.1"},"edition-number":"3","reference-count":0,"publisher":"Oxford University Press","content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2026,6,4]]},"DOI":"10.1093\/oed\/9352062916","type":"book-chapter","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T09:20:44Z","timestamp":1689672044000},"source":"Crossref","is-referenced-by-count":0,"title":["jessamy, n."],"prefix":"10.1093","member":"286","container-title":["Oxford English Dictionary"],"language":"en","deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T14:17:40Z","timestamp":1781014660000},"score":21.05643,"resource":{"primary":{"URL":"https:\/\/oed.com\/dictionary\/jessamy_n"}},"issued":{"date-parts":[[2026,6,4]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1093\/oed\/9352062916","published":{"date-parts":[[2026,6,4]]}}],"items-per-page":3,"query":{"start-index":0,"search-terms":null}}}